About 3DHEALS Company Directory:

3DHEALS updates this collection of public and private companies, government and non-government institutions, and any relevant research organizations in healthcare 3D printing, bioprinting, AR/VR, 3D technologies, on a weekly basis. Access to this directory is free to 3DHEALS Premium and Enterprise members. 

THIS CONTENT IS FOR PREMIUM AND ENTERPRISE MEMBERS ONLY.

Register

Add your company to 3DHEALS Directory:

(Please click the same above buttons for significant updates of your organizational information. Map is updated monthly.)

blank

International Stem Cell

International Stem Cell Corporation (OTCBB:ISCO) develops a powerful new stem cell technology called “parthenogenesis” that promises to significantly advance the field of regenerative medicine by addressing the significant problem of immune-rejection.

Headquarters 5950 Priestly Drive Carlsbad CA 92008 United States
  • blank
  • blank
  • blank
Categories: Stem Cells
Website: internationalstemcell.com/
LinkedIn: www.linkedin.com/company/1108951
Facebook: www.facebook.com/InternationalStemCellCorporation
Twitter: twitter.com/intlstemcell
CEO: ANDREY SEMECHKIN, PHD Chief Executive Officer and Co-Chairman of the Board Phone: +1-760-940-6383 Phone: +1-760-476-0600
Links:

Details

International Stem Cell Corporation (OTCBB:ISCO) develops a powerful new stem cell technology called “parthenogenesis” that promises to significantly advance the field of regenerative medicine by addressing the significant problem of immune-rejection.

Parthenogenesis utilizes unfertilized human eggs to create “parthenogenetic” stem cells (hpSC) that can be “immune-matched” to millions of persons of differing sexes and racial backgrounds. A relatively small number of hpSC lines could provide sufficient immune-matched cells to cover large parts of the world’s population. ISCO plans to create a bank of these valuable hpSC lines (UniStemCell™) to serve all populations across the world.

Human parthenogenetic stem cells have great therapeutic potential, yet do not require viable human embryos, thus avoiding ethical issues. ISCO’s scientists are focused on using hpSC to treat severe diseases of the eye, the nervous system and the liver where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells.

ISCO advances and operates three businesses: Lifeline Cell Technology, Lifeline Skin Care and Universal Stem Cell Bank.

CBD for pain is gaining traction as a complementary option for everyday discomfort, offering potential anti-inflammatory benefits and calmer sensations without strong sedatives. Results vary, so start with a low dose, choose reputable full- or broad-spectrum products, and monitor changes. Always consult a healthcare professional if you have underlying conditions or take other medications. cbdclub.top